Clene Inc. (NASDAQ:CLNN) — Market Cap & Net Worth
Market Cap & Net Worth: Clene Inc. (CLNN)
Clene Inc. (NASDAQ:CLNN) has a market capitalization of $47.80 Million ($47.80 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #22145 globally and #4927 in its home market, demonstrating a 6.63% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Clene Inc.'s stock price $3.86 by its total outstanding shares 12848513 (12.85 Million). Also see CLNN asset base for a full breakdown of the balance sheet.
Clene Inc. Market Cap History: 2018 to 2026
Clene Inc.'s market capitalization history from 2018 to 2026. Data shows growth from $2.54 Billion to $49.60 Million (172.36% CAGR). Also see CLNN cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Clene Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.00% | #638 of 976 |
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.00% | #2108 of 3165 |
Weight: Clene Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Clene Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Clene Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check CLNN live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
377.10x
Clene Inc.'s market cap is 377.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.78 Billion | $206.00K | -$19.28 Million | 13497.18x | N/A |
| 2021 | $1.05 Billion | $723.00K | -$9.74 Million | 1457.23x | N/A |
| 2022 | $256.97 Million | $473.00K | -$29.92 Million | 543.28x | N/A |
| 2023 | $77.09 Million | $654.00K | -$49.50 Million | 117.88x | N/A |
| 2024 | $68.23 Million | $342.00K | -$39.40 Million | 199.49x | N/A |
| 2025 | $75.42 Million | $200.00K | -$26.17 Million | 377.10x | N/A |
Competitor Companies of CLNN by Market Capitalization
Companies near Clene Inc. in the global market cap rankings as of September 18, 2026. Review Clene Inc. tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Clene Inc. by market ranking:
- Nestlé S.A (F:NESM): Ranked #90 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #105 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
- Danone SA (PA:BN): Ranked #594 globally with a market cap of $45.87 Billion USD ( €39.23 Billion EUR).
- Danone SA (F:BSND): Ranked #693 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Nestlé S.A | F:NESM | $224.33 Billion | €82.60 |
| #105 | Nestle S.A. | SW:NESN | $199.45 Billion | CHF77.66 |
| #594 | Danone SA | PA:BN | $45.87 Billion | €60.92 |
| #693 | Danone SA | F:BSND | $39.61 Billion | €12.00 |
Clene Inc. Historical Marketcap From 2018 to 2026
Between 2018 and today, Clene Inc.'s market cap moved from $2.54 Billion to $ 49.60 Million, with a yearly change of 172.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $49.60 Million | -34.24% |
| 2025 | $75.42 Million | +10.55% |
| 2024 | $68.23 Million | -11.50% |
| 2023 | $77.09 Million | -70.00% |
| 2022 | $256.97 Million | -75.61% |
| 2021 | $1.05 Billion | -62.11% |
| 2020 | $2.78 Billion | +3.24% |
| 2019 | $2.69 Billion | +5.86% |
| 2018 | $2.54 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Clene Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $47.80 Million USD |
| MoneyControl | $47.80 Million USD |
| MarketWatch | $47.80 Million USD |
| marketcap.company | $47.80 Million USD |
| Reuters | $47.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Clene Inc.
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral … Read more